Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glibenclamide 5mg tablets
0601021H0AAABAB
|
Glibenclamide | Glibenclamide | Endocrine System | 15 |
|
Glibenclamide 2.5mg tablets
0601021H0AAAAAA
|
Glibenclamide | Glibenclamide | Endocrine System | 13 |
|
Glibenclamide 5mg/5ml oral liquid
0601021H0AAAJAJ
|
Glibenclamide | Glibenclamide | Endocrine System | 6 |
|
Glibenclamide 15mg/5ml oral liquid
0601021H0AAAMAM
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 2.5mg/5ml oral liquid
0601021H0AAAKAK
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 600micrograms/ml oral suspension sugar free
0601021H0AAAPAP
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 625micrograms/5ml oral liquid
0601021H0AAAIAI
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 6mg/ml oral suspension sugar free
0601021H0AAAQAQ
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 7.5mg/5ml oral liquid
0601021H0AAANAN
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.